InfraMed will give sufferers better sleep, comfortable travel, and relief from restless legs. Our patented technology delivers a targeted infrared wavelength to restless legs.

About

Clinicians have been using similar technology to treat neuropathy in patients for almost a decade. Ulrike Mitchell, a BYU professor and InfraMed founder, first discovered this method when she was researching the affect of infrared light in neuropathy patients. When conducting her research, multiple individuals returned after the trials to report that beyond neuropathy, their restless legs symptoms had disappeared. This lead to subsequent research and trials that have culminated in our patented offering for restless legs relief. The resources for restless legs sufferers are limited. Common solutions range from compression socks, to medical marijuana, to dopaminergic drugs developed for Parkinson’s Disease and not for restless legs. We provide non-invasive relief has shown greater efficacy than the leading drugs.  As much as 10% of the U.S. population suffer from restless legs. Symptoms are most common at night and when sitting for long periods of time. Accordingly, we have developed a comfortable wearable device that can provide unprecedented relief even while traveling. Our pad uses patented infrared technology to increase local blood flow relieving the discomfort and pain associated with restless legs. More comfort, more rest, and no drugs.   

Register for free for full unlimited access to all innovation profiles on LEO

  • Discover articles from some of the world’s brightest minds, or share your thoughts and add one yourself
  • Connect with like-minded individuals and forge valuable relationships and collaboration partners
  • Innovate together, promote your expertise, or showcase your innovations